AnteoTech’s AnteoBind™ technology supports first-of-its-kind COVID-19 Home Test
Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity
Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA
Companion diagnostic can help guide treatment decisions in cases of NSCLC
Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Focusing on innate immunity opens way for precision medicine approaches to AD
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency
Increasing Portuguese market presence by enhancing sales and after-sales support networks
RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein
Watch our curated collection of The Scientists' Channel interviews from some of the experts joining us at this year's summit
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
The SARS-CoV-2 Rapid Antigen Test Nasal uses a nasal swab to quickly and conveniently collect specimens from people suspected of having an active infection
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar